SECsense Logo

Regeneron Pharmaceuticals 8-K Report: Key Updates & Insights (October 2025)

$REGN
Form 8-K
Filed on: 2025-10-06
Source
Regeneron Pharmaceuticals 8-K Report: Key Updates & Insights (October 2025)

Based on the provided section of a financial report, here are the key insights:

  1. Entity Information:
  • Company Name: Regeneron Pharmaceuticals, Inc.
  • CIK: 0000872589
  • SEC File Number: 000-19034
  • EIN: 13-3444607
  • Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707
  • Phone Number: 914-847-7000
  1. Filing Type:
  • This is an 8-K filing, which typically reports significant events that shareholders should know about.
  1. Date of Filing:
  • Filing Date: October 6, 2025
  1. Stock Information:
  • Security Type: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: REGN
  • Exchange: NASDAQ
  1. Measurement Units:
  • Financial figures are presented in USD (United States Dollar).
  • Shares are also a unit of measurement mentioned.
  1. Context Information:
  • The context of the report is as of October 6, 2025, which indicates that the data provided is as of this specific date.

Insights:

  • The 8-K filing indicates that Regeneron Pharmaceuticals is communicating important information to its investors or the market as of the specified date.
  • The company's common stock is listed on NASDAQ, which is relevant for potential investors or stakeholders looking for trading information.
  • The low par value of the common stock suggests a typical structure for shares in a publicly traded company, allowing for flexibility in share issuance and potential future stock splits.

This information is critical for investors, analysts, and stakeholders monitoring Regeneron's performance and market activities.